This is general marketing information, not legal advice. Regulations, statutes, platform policies, and enforcement positions change. Qualified counsel should review the specific license, market, claim, audience, and channel.
The rules that actually shape the copy
California’s advertising provisions set the state-level frame. The Department of Cannabis Control regulations revised January 1, 2026 are the primary reference used here. Advertising and marketing must be truthful and appropriately substantiated, and must display the licensee's license number. Placement in broadcast, cable, radio, print, or digital media is permitted only where at least 71.6% of the audience is reasonably expected to be 21 or older, based on reliable, current audience-composition data.
Any direct, individualized marketing communication controlled by the licensee requires a method of age affirmation confirming the recipient is 21 or older before the communication begins.
On top of that, marketing cannot be false or misleading in any material particular, or create a misleading impression. It cannot be designed to encourage people under 21 to consume cannabis, or be attractive to children. Billboards on interstate highways or state highways crossing the California border are prohibited, as are advertising signs within 1,000 feet of a daycare center, a school teaching kindergarten through grade 12, a playground, or a youth center.
Platforms add separate eligibility and content rules. Google’s current recreational-drugs policy prohibits ads for substances that induce a recreational high and permits a limited certified path for certain topical, hemp-derived CBD products at or below 0.3 percent THC. Review the current Google Ads policy and the current Meta policy available in the advertiser account before building a campaign. A lawful campaign can still be ineligible under platform rules.
The claims that create the most trouble
Health and effect claims
The highest-risk category and the one marketers reach for most instinctively. Language implying a product treats, prevents, or relieves a medical condition takes the brand into territory it almost certainly cannot substantiate. Softer framings — anxiety, sleep, pain, recovery — carry the same problem when they function as a therapeutic promise.
The workable move is to describe the product rather than the outcome in the consumer's body: the cultivar, the format, the process, the intended occasion. That is a real creative discipline, and it usually produces better copy than the claim it replaced.
Potency and quality superlatives
"Strongest," "cleanest," "purest," "best in California" are comparative claims, and a comparative claim is substantiable only with evidence that supports the comparison. Testing data supports a stated cannabinoid figure; it does not support "the most potent flower in the state."
If you cannot show the work behind a superlative, cut it. In a market where every brand claims premium, a specific verifiable detail outperforms an unbackable superlative anyway.
Awards, results, and partnerships
Name only what happened, exactly as it happened. An award has a year, a category, and an awarding body — all three belong in the claim or none of it does. Implying a partnership, a stocking relationship, or a client engagement that was not agreed is both a substantiation problem and a commercial one.
Origin and process claims
"Small batch," "single source," "sun grown," "solventless," "craft" all carry factual content that someone can check. Use them where they are accurate and be prepared to explain the production reality behind them.
Where the rules bite hardest in practice
Age-gating and placement do more day-to-day damage to campaigns than claim language does. The 71.6% audience threshold means you need current audience-composition data for a placement before you buy it — an assumption about who reads a publication is not the same as data about who reads it. Ask the publisher for it, and keep the record.
Direct channels carry the age-affirmation requirement, which shapes how you build email and SMS lists: the affirmation belongs in the signup flow, not as a note in the footer. A list built without it is a list you may not be able to market to.
Creator content is where cannabis marketing compliance most often fails, because the brand does not write the words. A creator's freehand caption can introduce a health claim, an unsubstantiated superlative, or a missing disclosure in a single line. The FTC endorsement guidance says material connections should be disclosed clearly and conspicuously. Both the advertiser’s compliance program and the endorser’s disclosure matter.
Brief creators on what they cannot say with the same specificity you brief them on what to show — the campaign execution work is where this is won or lost.
Building claim discipline into production
A practical control is a substantiation register: for every material claim in a piece of copy, record the claim, the evidence, where the evidence lives, who verified it, and the date. It sounds bureaucratic and it reduces avoidable late-stage rewrites, because when a claim is challenged you either have the file or you rewrite under pressure.
Bake the review into the workflow early. A claim caught at the copy stage costs a sentence; the same claim caught at print costs the run. Give one person authority to approve claim language, and let writers escalate rather than guess.
Keep a living list of the language your brand has already decided against. Most claim problems are repeats, and a shared do-not-use list prevents the same sentence being reinvented quarterly across your social and content channels.
Tradeoffs
Maximum caution produces copy so hedged it says nothing, which is its own failure — a page that commits to nothing does not persuade anyone. The goal is not to eliminate claims but to make the ones you keep defensible.
There is a real cost to the discipline: substantiation takes time, and a review layer slows publishing. Brands operating in fast-moving culture have to decide what they will pre-clear so that time-sensitive content can ship inside the guardrails rather than waiting on individual approval.
And rules differ by state and change over time. A national brand cannot run one compliance standard everywhere and should not assume California's requirements are representative — several states are stricter on specific formats and channels.
What most operators miss
Compliance is usually treated as a filter applied after the creative is made. That is the expensive order of operations. When constraints are known at the brief stage, they shape ideas that were always going to work; applied at the end, they gut ideas that were built on a claim you cannot make.
The other miss: the substantiation file is a marketing asset, not just a defense. A brand that can actually show its testing, its process, and its sourcing has material most competitors cannot produce — and specific, verifiable detail is more persuasive to a skeptical buyer than any superlative you were considering instead.
Frequently asked questions
Can cannabis brands mention effects at all?
Language that functions as a therapeutic or medical promise is the high-risk zone, and effect claims generally require substantiation the brand is unlikely to hold. Describing the product, format, cultivar, and intended occasion is the safer and usually stronger approach. Have qualified review for anything close to the line.
Does the license number have to appear on every piece of marketing?
California requires the licensee's license number to be displayed on advertising. Treat it as a standing layout requirement rather than a case-by-case decision, and confirm the current requirement for your license type and channel.
Who is responsible if a creator makes a non-compliant claim?
Practically, the brand carries the exposure and the reputational cost regardless of who typed the caption. Brief creators explicitly, require disclosure of the material connection, and review content before it posts wherever the agreement allows.
The operating takeaway
Write claims you can prove, place them where the audience is verifiably adult, keep the license number on the layout, and put the constraints in the brief rather than the final review. High Rise has worked inside these rules since 2012, and teams can move more confidently when writers know which claims are approved, which evidence supports them, and which issues require escalation.
Talk to High Rise about building a content system that ships fast and stays defensible.